This article was originally published in The Tan Sheet
Michael Polk is tapped President Americas by Unilever, the firm announces Dec. 19. Polk will replace John Rice, who will step down in March 2007 to retire after 25 years of service. Currently serving as Group VP and President Unilever United States, Polk is credited with successfully integrating the U.S. business and sustaining growth momentum. He joined Unilever in 2003 after 16 years at Kraft Foods. Rice headed the Americas unit for two years...
You may also be interested in...
The European Medicines Agency says that Shionogi’s novel antibiotic, Fetcroja, should be approved for use across Europe but that Lilly's migraine drug, Emgality, should not be authorized for the extended indication of episodic cluster headache.
Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.